She was legally blind and used a motorized wheelchair, but she managed to capture what she called the “ironic reality” of New ...
In astrology, your rising sign describes your appearance and the first impressions you make, which includes your beauty look.
A mum who suffered from a severe headache died just two weeks later - after doctors discovered a deadly brain tumour. Nicolette Richardson, 41, put her headache down to her physically demanding job as ...
Jack Dykinga won a Pulitzer in Chicago, then came West for a celebrated career in nature photography. And at age 82, after a ...
Doctors say early detection is critical because the early phases don't have any symptoms that you can feel or see.
While decades of research and advanced treatments have prolonged the lives of cancer patients in the last 20 years, a possible cure remains elusive. As the world at large continues to grapple with ...
As women all over the world celebrate International Women’s Day, 4 Communities by Communities (4CbyC) is shining a light on the incredible stories of women fighting cervical cancer. Read Also ...
2d
Newspoint on MSNWorld Glaucoma Day: Understanding the Risks, Symptoms, and PreventionGlaucoma is a serious eye disease that, if left untreated, can lead to blindness. According to reports, 11.9 million people ...
3d
LondonWorld on MSNWorld Glaucoma Week encourages people to think of eye healthAs part of this year’s World Glaucoma Week, Glaucoma UK is encouraging people to make eye health part of their conversations ...
As the world marks International Women’s Day, 4 Communities by Communities (4CbyC) is spotlighting the resilience of women battling cervical cancer. Their stories are not just about survival but ...
Chief Medical Officer for England, Dame Sally Davies, has championed the use of genomic data to help treat cancer. But is the NHS ready to use this, and other forms of real-world data, to find new ...
Hundreds of people in England with a rare form of cancer affecting the eye will soon be able to access a pioneering therapy based on T-cell receptor (TCR) technology, developed by Immunocore.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results